SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac and Butantan Join Efforts to Advance the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III Beijing (China), Sao Paulo, (Brazil), June 11th, 2020 Science Sinovac has made significant progress in the development of CoronaVac. Promising preclinical results regarding Coron]